NCI Assay Portal Webinar

December 11, 2019 1:00 p.m. - 1:45 p.m. ET

Drs. Mehdi Mesri, Karen Ketchum, and Jeffrey Whiteaker will be providing a brief overview of NCI's Proteomic (CPTAC) Assay Portal. 

With more than 2,300 proteomic assays designed and optimized for mass spectroscopy available, the speakers will talk about the Assay Program, show participants how to navigate the website, as well as submit an assay. Registration is required.

To learn more about the user experience, registrants are invited to submit questions to with "OCCPR Webinar: ASSAY PORTAL" in the subject line by 12:00 p.m. ET on Friday, December 6, 2019. A limited number of questions submitted during the webinar will be addressed.

This webinar is presented by the Office of Cancer Clinical Proteomics Research (OCCPR). OCCPR aims to improve prevention, early detection, diagnosis, and treatment of cancer by enhancing the understanding of the molecular mechanisms of cancer, advancing proteome/proteogenomic science and technology development through community resources (data and reagents), and accelerating the translation of molecular findings into the clinic.

Mehdi Mesri, M.Med.Sci., Ph.D

Dr. Mesri is a program director at NCI's Center for Strategic Initiatives.

Karen Ketchum, Ph.D.

Dr. Ketchum is the director of Strategic Solutions -- Big Data and Precision Medicine at Enterprise Science and Computing (ESAC), Inc.

Jeffrey Whiteaker, Ph.D.

Dr. Whiteaker is the director of proteomics, Paulovich Lab at Fred Hutchinson Cancer Research Center.

Vote below about this page’s helpfulness.

Enter the characters shown in the image.